DiaMedica Therapeutics Inc.

SEC 4 · Filed

0001872863-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 2, 2026

Grant, award or other acquisition by Semba Charles Pauling

Security
Common Stock
Code
A
Shares
3,355
Price per share
8.42
Structured facts
{
  "code": "A",
  "date": "2026-01-02",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Shares are issuable upon settlement of restricted stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.\""
  },
  "owners": [
    {
      "cik": "0001872863",
      "name": "Semba Charles Pauling",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "47963",
  "price": "8.42",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "3355",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}